|
TMEM185B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.53574938824386E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.33695310167559E-12 |
| Normal-vs-Stage2 |
2.41650000010196E-08 |
| Normal-vs-Stage3 |
1.80955250783654E-12 |
| Normal-vs-Stage4 |
1.63191682389652E-12 |
| Stage1-vs-Stage2 |
6.633400E-01 |
| Stage1-vs-Stage3 |
1.170050E-01 |
| Stage1-vs-Stage4 |
4.263900E-03 |
| Stage2-vs-Stage3 |
1.565790E-01 |
| Stage2-vs-Stage4 |
3.149600E-02 |
| Stage3-vs-Stage4 |
2.499000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.51121345939964E-12 |
| Normal-vs-AfricanAmerican |
7.41280000049471E-07 |
| Normal-vs-Asian |
1.90550000223055E-08 |
| Caucasian-vs-AfricanAmerican |
6.517200E-01 |
| Caucasian-vs-Asian |
2.165200E-01 |
| AfricanAmerican-vs-Asian |
6.839600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.37587727269783E-14 |
| Normal-vs-Female |
6.08169070659415E-12 |
| Male-vs-Female |
1.632220E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62636570877339E-12 |
| Normal-vs-Age(41-60Yrs) |
4.72399896978004E-13 |
| Normal-vs-Age(61-80Yrs) |
1.5887291482386E-13 |
| Normal-vs-Age(81-100Yrs) |
2.056400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.925750E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.339800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.601000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.126200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.386000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.671400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.580770E-01 |
| Classical-VS-Follicular |
9.420300E-02 |
| Classical-VS-Other |
9.111700E-02 |
| Classical-VS-Normal |
5.14579490129563E-11 |
| Tall-VS-Follicular |
9.463800E-01 |
| Tall-VS-Other |
2.792400E-01 |
| Tall-VS-Normal |
1.32469590852224E-11 |
| Follicular-VS-Other |
4.364000E-01 |
| Follicular-VS-Normal |
2.22377671832419E-12 |
| Other-VS-Normal |
8.30510000000562E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
3.68705066478014E-13 |
| N0-vs-N1 |
1.826950E-01 |
|
|
